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ABSTRACT 
In the kidney, both anions, phosphate and sulfate are almost freely filtered 
and afterwards reclaimed (reabsorbed) to a large extent from tubular fluid 
along the proximal tubules. Under normal dietary conditions, fractional 
excretion of these anions is approximately 10%. Reabsorption of both anions 
occurs along the proximal tubules by active, saturable  and regulated 
transepithelial processes. Most of the transporters involved in renal handling 
of phosphate and sulfate have been identified and their transport functions as 
well as their cellular localizations have been described in detail. The role of 
these transporters in the renal handling of phosphate and sulfate has been 
investigated by the use of several mice knock out models and also by analysis 
of several inherited human diseases.  Numerous hormonal and non hormonal 
factors, have been described that alter renal excretion of phosphate or sulfate 
by mechanisms that alter the abundance of known phosphate/sulfate 
transporters and and consequently renal excretion. These mechanisms 
contribute to the homeostasis of the extracellular concentrations of phosphate 
and sulfate.  
 
PHOSPHATE 
Inorganic phosphate is a nutrient that is essential for many biological 
processes, such as bioenergetics, metabolic regulation, and for structures 
such as bones and membranes. In addition, phosphate participates in acid-
base balance by contributing to urinary buffering. Approximately 85% of total 
phosphate is located in bone and teeth, 14 % resides in soft tissues and 
erythrocytes and only 1% circulates as free phosphate in extracellular fluids.     
Dietary intake of phosphate is closely related to the intake of meats, 
vegetables, and dairy products. As general estimates, milk and milk products 
contain ~250 to 300 mg of phosphorus per typical serving; meat and fish ~100 
-200 mg; vegetables, ~50 -100 mg; and fruits and grain products, 10-50 mg. 
2 
 
The recommended daily dietary allowance for phosphorus is around 800 mg 
for adults and 1200 mg for children between ages of 11 and 18 years (see 
http://lpi.oregonstate.edu/infocenter/minerals/phosphorus). A minimum daily 
requirement is uncertain because negative balance is difficult to achieve in 
healthy persons. In the absence of abnormalities that affect the 
gastrointestinal or renal handling of phosphate and/or bone metabolism, the 
overall output of phosphate adjusts to the intake over a wide range (228).  
Organic phosphates ingested in foods are hydrolyzed in the gastrointestinal 
tract to form inorganic phosphate. Phosphate absorption along the 
gastrointestinal tract appears to involve two components: i) a transcellular 
absorptive component, that involves type ll and type lll Na/Pi-cotransporters 
(108, 206, 251) and ii) a concentration- or load- dependent absorptive 
component that may represent paracellular diffusion, that, however, is poorly 
characterized. The sum of these processes results in an overall fractional 
absorption of phosphate that ranges between 65% and 70% of the amount 
ingested (229). Notably, segmental distribution of absorption of phosphate 
varies among different species. In humans and rats most of the ingested 
phosphate is absorbed in the upper intestinal segments duodenum and 
jejunum, whereas in mice, most of the phosphate absorption occurs in the 
ileum (206, 207, 244). The role of the colon is uncertain.  
Overall, control of the extracellular concentration of phosphate depends to a 
large extent on mechanisms that govern renal excretion of phosphate. Renal 
excretion of phosphate, and to a lesser extent gastrointestinal absorption of 
phosphate, is controlled by complex regulatory networks that involve several 
organs and several endocrine factors (31, 91, 169, 206, 208, 279).  
 
 
PLASMA PHOSPHATE CONCENTRATION 
In plasma, phosphate exists in both the monovalent and the divalent form. 
Based on the pK-value of 6.8, at blood pH of 7.4, 72 % of plasma phosphate 
is present in the divalent (HPO4
=) and 28 % is present in the monovalent 
(H2PO4
-) form. In adult humans, total steady-state phosphate concentration in 
the plasma ranges between 0.8 and 1.2 mM (2.5 to 3.75 mg per deciliter). 
Different species maintain different normal values for plasma phosphate 
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concentrations (164). These differences have been correlated with basal 
metabolic rates. High plasma levels of phosphate occur in mammalian 
species that exhibit high rates of oxygen consumption and ATP production 
(267). Plasma phosphate concentrations exhibit diurnal fluctuation due to 
mechanisms that are not fully understood. In individuals on normal diets, 
several studies showed consistently that serum concentration of phosphate is 
highest after midnight and lowest around between morning and midday (205, 
238). These diurnal variations are closely matched by a diurnal variation of 
renal phosphate excretion (37). 
Deviations from normal serum phosphate concentrations cause severe clinical 
disorders. Even slight elevations have been associated with increased rates of 
death due to cardiovascular complications (292) that are common among 
patients with chronic kidney disease (136). On the other hand, prolonged 
hypophosphatemia, caused by e.g. malabsorption or inherited disorders such 
as X-linked hypophosphatemia (287), results in a number of symptoms such 
as osteomalacia, hypercalciuria and bone demineralization (7, 153).  
  
 
METABOLIC REQUIREMENT FOR PHOSPHATE  
Inorganic phosphate serves as a cofactor in pathways of energy metabolism 
such as glycolysis and oxidative phosphorylation. Additionally, phosphate is a 
cofactor for enzymatic activities involved in a number of metabolic pathways, 
such as ammoniagenesis or glycogenolysis, and intracellular signaling 
pathways (36, 42, 43). Moreover, phosphate is required for DNA synthesis 
and cell replication. Values for intracellular inorganic phosphate 
concentration/activity are difficult to determine because of the high content 
and rapid turnover of various organic phosphates. By 31P-NMR, intracellular 
concentration of phosphate has been estimated to be around 0.7 mM. This 
value is approximately 30% of values determined chemically (100). 
When isolated proximal convoluted tubules are luminally perfused with 
phosphate-free solution, net sodium transport is eliminated and only partially 
restored by subsequent perfusion with phosphate-containing fluid. These 
changes occur inspite of 2 mM phosphate in the bathing medium. Of interest, 
inhibition of D-glucose transport protects tubular function from limited 
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phosphate availability (41). These studies indicate that the uptake of luminal 
phosphate represents a major source for intracellular organic and inorganic 
phosphates and additionally, that glucose metabolism and mitochondrial 
respiration compete for a limited pool of available phosphate (41, 42). Similar 
phenomena have been described in other tissues as “the Crabtree effect”. 
Limited phosphate availability could impair mitochondrial uptake of substrates 
whose transport is coupled directly or indirectly to phosphate. Support for this 
possibility derives from observations that mitochondrial substrates such as 
succinate, malate, citrate, and glutamate partially restore the transport 
function of phosphate-limited tubules (117). Alternatively, limited phosphate 
availability may impair the mitochondrial uptake of calcium or the maintenance 
of the mitochondrial potential.   
 
RENAL HANDLING OF PHOSPHATE 
The overall renal handling of phosphate involves glomerular filtration and 
tubular reabsorption. There is no evidence for significant secretion of 
phosphate in kidneys of mammals (115). Phosphate reabsorption displays 
saturability, but maximal rates vary considerably in response to phosphate 
intake and levels of different phosphaturic factors. The tubular transport 
maximum (Tm) for phosphate, therefore, is a variable rather than a constant 
parameter. As Tm varies with the glomerular filtration rate (GFR), the renal 
threshold for phosphate (Tm/GFR) should be preferred as a description of the 
overall renal handling of phosphate. Its normal range lies between 0.77 to 1.4 
mMol/L (317). In response to extremes of phosphate intake, the kidneys may 
excrete close to 100% of the filtered load or as little as none. For individuals in 
phosphate balance, the daily urinary excretion of phosphate equals the net 
amount absorbed from the intestinal tract and usually represents 10-20 % of 
the amount filtered (fractional excretion).   
The phosphate concentration in the glomerular ultrafiltrate is determined by 
the plasma phosphate concentration and the Donnan equilibrium distribution. 
Measured values of concentrations of phosphate in the ultrafiltrate range 
between 92 % and 98% of the concentration in plasma water or about 90% of 
that in total plasma (175). Ultrafilterability declines with increases in plasma 
calcium concentration in the range between 2.6 mM and 4.6 mM. At very high 
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plasma calcium concentration ultrafilterability may decrease to about 78% 
(126). 
 
Localization of Renal Phosphate Reabsorption 
Under normal conditions, phosphate reabsorption occurs mainly and 
essentially only in the proximal tubules. Using free-flow micropuncture 
techniques, it was observed that the accessible portion of the proximal tubule 
reabsorbed 76% of the phosphate that was filtered (278). The fraction of 
filtered phosphate remaining at the end of the proximal tubule (24%) was not 
different from values measured at the early distal tubule or in the urine 
indicating that there was no evidence for any net transport of phosphate distal 
to the accessible proximal tubule when the parathyroid glands were intact. On 
the other hand, other studies provided evidence for a possible, distal tubular 
reabsorption of phosphate of approximately 5 to 10% of the filtered phosphate 
(9). Molecular mechanisms eventually involved in distal tubular reabsorption 
of phosphate are, however, completely unknown. 
Phosphate transport in the proximal tubule displays both axial and 
internephronal heterogeneity. The latter refers to differences among different 
populations of nephrons such as superficial versus juxtamedullary. 
Microperfusion studies of individual proximal tubules demonstrated that 
phosphate transport rates per unit length did not differ between segments 
derived from superficial versus juxtameduallary nephrons (210). Therefore, 
internephron heterogeneity may arise from differences in the lengths or axial 
composition of superficial and juxtamedullary nephrons. With regard to axial 
heterogeneity, phosphate reabsorption in the earliest portion, the proximal 
convoluted tubule (S1), is estimated to be 3 to 4 times higher per unit length 
compared to the convoluted S2 portion (210, 303). In the proximal straight 
tubule (S3), rates of phosphate reabsorption are even lower (82). In 
agreement, higher phosphate transport rates have been demonstrated in 
brush border membrane vesicles isolated from superficial cortex compared to 






CELLULAR MECHANISMS OF PHOSPHATE TRANSPORT 
Phosphate reabsorption in the proximal tubule is fundamentally an 
unidirectional, transcellular process that is strictly dependent on the presence 
of sodium-ions. A small component of bath-to-lumen flux was reported that 
may occur via a paracellular pathway. If existing at all, this pathway is not 
affected by factors that inhibit or enhance phosphate movement from lumen to 
bath (83, 224, 271).  
Phosphate transport across the luminal, apical membrane occurs via sodium-
dependent secondary active transport processes that are driven by active 
extrusion of sodium-ions at the basolateral surface mediated by Na/K-
ATPase. Basolaterally located exit transport mechanisms complete 
transcellular movement of phosphate.  
 
Phosphate Entry  
At the apical side of proximal tubular cells phosphate uptake occurs against its 
own electrochemical gradient. At a negative membrane potential of 
approximately -60 mV, the free intracellular concentration of phosphate at 
equilibrium should be roughly 10-times lower than in the extracellular space. 
However, several measurements indicated that the intracellular concentration 
of phosphate is around 1 mM and therefore far above the predicted low 
intracellular concentration of phosphate (100). This suggests that the apical 
entry of phosphate must be energized. In fact energization is achieved by 
coupling with sodium-flux that occurs by secondary active sodium-dependent 
phosphate cotransporters.  
Strict dependency of phosphate transport across the apical membrane in 
proximal tubules on the presence of sodium-ions has been demonstrated in 
several in vivo (tubules) and in vitro (cells, tubules, purified membranes) 
assays (83, 296). The major action of sodium-ions is to activate the binding of 
phosphate to the transport site (312). Sodium dependent transport of 
phosphate (Na/Pi-cotransport) has been extensively characterized by the use 
of proximal tubular brush border membrane vesicles isolated from kidneys of 
different species (83, 224, 296) and by electrophysiological methods using 
oocytes from Xenopus laevis expressing single Na/Pi-cotransporters (98, 99, 
312). Sodium dependence and other characteristics (e.g. pH dependence) of 
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Physiologically relevant Na/Pi-cotransporters identified thus far and localized 
at the apical membrane of proximal tubules belong to the solute carrier 
families SLC20 and SLC34 (see www.bioparadigms.org/slc/intro.htm) (Figure 
1). Some members of the SLC17 family were reported to exhibit Na/Pi-
cotransport activity in heterologous expression systems as well, however, it 
appears unlikely that these transporters play a role in renal handling of 
phosphate. SLC17a1 (NaPi1) has been cloned based on its (weak) Na/Pi-
cotransport activity (324) and has been localized at the brush border 
membrane of proximal tubules (64). Its role in renal phosphate handling is 
rather unlikely as neither PTH nor dietary phosphate regulate NaPi1 protein 
abundance (224). Furthermore, after expression in oocytes of Xenopus laevis, 
detailed analysis suggested that NaPi1 is transporting various organic anions 
(47, 246). Moreover, as demonstrated with purified and reconstituted NaPi1 
protein, NaPi1 may act as a voltage and chloride dependent urate exporter in 
proximal tubules (135). As a single nucleotide polymorphism in SLC17A1 has 
been associated with gout (80), thus urate transport by NaPi1 could be of 
particular importance in the development of this disease. Another member of 
the SLC17 family, SLC17A3, was also shown to be localized at the brush 
border of proximal tubules (139). After expression of SLC17A3 in Xenopus 
oocytes, transport of phosphate could be demonstrated that was dependent 
on the presence of sodium-ions. However, the role of SLC17A3 in renal 
handling of phosphate is not clear. Rather, SLC17a3 appears to be an anion 
efflux transporter for urate and loop diuretics (145).  
The two members of the SCL20 family [SLC20a1 (PiT1) & SLC20a2 (PiT2)] 
were originally identified as retroviral receptors and later on demonstrated to 
exhibit Na/Pi-cotransport activity (61, 148). In kidney, PiT2 was localized at 
the brush border membrane in proximal tubules (309).  In rat kidney PiT2 was 
detected in S1 and to a lesser degree in S2 segments (236). The localization 
of the PiT1 protein remains to be determined. Na/Pi-cotransport by PiT 
proteins is electrogenic due to a stochiometry of 2Na+ to 1HPO4
-  (98, 245). 
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PiT transporters do not transport sulfate, but interaction with arsenate has 
been demonstrated (245, 312). The role of PiT2 in proximal tubular 
reabsorption of phosphate under normal physiological conditions was 
suggested to be marginal (310). Na/Pi-cotransport activity of PiT transporters 
is higher at more acidic pH-values (245, 310), therefore PiT mediated 
phosphate reabsorption may be of primary importance under pathological 
conditions (e.g. acidotic conditions). The precise role of PiT2 in overall renal 
handling of phosphate and its regulation remains to be determined.  
Both, NaPi-lla (SLC34A1) and NaPi-llc (SLC34A3) have been localized at the 
luminal membrane of proximal tubules (98, 224, 236, 315). Abundance of 
NaPi-lla is highest in S1 segments and decreases towards S3 segments. 
NaPi-llc has been localized only in the S1 segment (236). Transport kinetics of 
both isoforms have been extensively studied after heterologous expression in 
oocytes of Xenopus laevis (98, 99). A fundamental difference between NaPi-
lla and NaPi-llc lies in the coupling to Na+-ions. Whereas 3 Na+ ions are 
transported together with one divalent phosphate ion (HPO4
2-) by NaPi-lla, 
only 2 Na+-ions are transported with one HPO4
2- -ion by NaPi-llc. Thus, Na/Pi-
cotransport by NaPi-lla is an electrogenic process, whereas Na/Pi-cotransport 
by NaPi-llc is an electroneutral process. Both cotransporters show similar pH 
dependence with higher rates at more alkaline pH-values (315). 
The roles of NaPi-lla and NaPi-llc cotransporters in proximal reabsorption of 
phosphate can be deduced from several observations made with different 
knock out mouse models and from observations made with several genetic 
diseases in humans (216). In mice, the important role of NaPi-lla has been 
documented by knocking out the Npt2 gene (19, 288). These mice are 
hypophosphatemic due to phosphate wasting that can be explained by an 
approximately 70% reduced Na/Pi-cotransport rate in isolated brush border 
membranes. In humans, the role of NaPi-lla has been documented less well. 
Although genetic variants within the NPT2a gene are often observed, these 
polymorphisms could not be conclusively linked to renal phosphate anomalies 
(165). On the other hand, an in-frame duplication of a stretch of seven amino 
acids has been reported in two siblings of a family with hypophosphatemic 
rickets (190). Renal wasting of phosphate in these patients is associated with 
Fanconi’s syndrome, suggesting that either the duplication of  the described 
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amino acid motif in NaPi-lla proteins may also affect other proximal tubular 
transporters as well, e.g. by interfering with sorting or that the genetic defect 
lies in another gene not identified yet. 
In contrast to NaPi-lla, ablation of the NaPi-llc cotransporter did not impair 
homeostasis of phosphate nor was renal reabsorption of phosphate affected 
in adult mice (264). These observations suggested that, in adult mice, NaPi-llc 
plays a minor role in overall renal handling of phosphate. However, opposite 
to mice, in patients with hereditary hypophosphatemic rickets with 
hypercalciuria (HHRH, OMIM #241530) mutations within the NaPi-llc gene 
have been described that explain the renal wasting of phosphate in these 
patients (7, 28, 185, 240). Altogether, current findings suggest that NaPi-lla 
and NaPi-llc Na/Pi-cotransporters represent the major players in renal 
handling of phosphate but may contribute differently in different species.   
 
Phosphate Exit 
The molecular identity of phosphate transport across the basolateral 
membrane is currently not known. Based on basolateral membrane 
preparations, several transport mechanisms have been proposed. However, 
because purified basolateral membrane fractions are relatively undefined, it 
has remained difficult to demonstrate that the transport phenomenon does not 
represent contamination from other membranes, especially mitochondrial or 
brush border material.  
Uptake of phosphate into basolateral membrane vesicles from dog kidney 
demonstrated features different from uptake in brush border membrane 
vesicles. Although sodium-dependency has been demonstrated, uptake into 
basolateral membrane preparations lacked pH-sensitivity (261). Even if 
present in basolateral membranes in vivo, an electrogenic, sodium gradient-
dependent transport mechanism would favour a basolateral entry – rather 
than exit- of phosphate, and thus such a mechanism is difficult to integrate 
into models of net transcellular transport of phosphate. However, it has been 
proposed that such a mechanism could be involved in protecting the proximal 
tubule from limited availability of intraluminal phosphate (262). 
Other investigations suggested an anion-exchange mechanism based on the 
observation that preloading basolateral vesicles with phosphate stimulated 
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phosphate uptake in the absence of sodium (119, 187). For an anion-
exchange mechanism to achieve net exit of phosphate, some other counter-
ion must be exchanged. The identity of such a counter-ion is not known. 
Experimental evidence was provided that the phosphate exchange 




REGULATION OF PHOSPHATE EXCRETION 
Excretion of phosphate is tightly controlled and adjusted to the metabolic 
needs by a long list of hormones and metabolic factors which primarily affect 
the abundance of Na/Pi-cotransporters residing in proximal tubular brush 
border membranes and therefore net rate of reabsorption of phosphate. 
These factors are integrated into complex regulatory networks that acutely 
and chronically regulate renal phosphate reabsorption. These networks 
comprise different organs such as bone, small intestine, and parathyroid 
glands (6, 31, 34, 83, 160, 208, 279).   
 
Parathyroid Hormone 
Parathyroid hormone (PTH) primarily regulates calcium homeostasis but in 
addition regulates serum phosphate levels by controlling proximal tubular 
phosphate reabsorption (107). Acute administration of PTH causes an 
increase of phosphate excretion within minutes that lasts for several hours 
(35, 98). PTH has the potential to reduce phosphate transport along the entire 
proximal tubule. The action of PTH in different proximal tubular segments may 
be influenced by excessive or restricted dietary phosphate availability (112). In 
addition, PTH also inhibits proximal reabsorption of sodium and bicarbonate 
by inhibition of the amiloride sensitive sodium-proton exchanger NHE3 (5) and 
stimulates production of 1, 25-dihydroxyvitamin D3 (88). 
In proximal tubules, PTH exerts its effect via the PTH receptor PTHR1, which 
is localized at the basolateral as well as at the luminal membrane. Apical 
PTHR1 is coupled to Gq and activates a PLC/IP3/Ca
2+/PKC pathway, while 
basolateral PTHR1 is coupled to Gsα and activates a cAMP/PKA pathway 
(293). Activation of both PTHR1 pools results in increased excretion of 
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phosphate due to a decrease of the abundance of apical Na/Pi-
cotransporters. In-vivo studies using different PTH analogs demonstrated that 
down-regulation of the Na/Pi-cotransporter NaPI-lla (see below) occurs 
primarily via the cAMP/PKA pathway (225) 
PTH provokes a decrease of Na/Pi-cotransporters NaPi-lla and NaPi-llc, yet 
by different mechanisms and time courses (209, 236, 265, 266). After 
intravenous injection of PTH, a decrease of apical abundance of NaPi-lla 
proteins is detectable after 15 min and persists for several hours, while a 
decrease of the abundance of NaPi-llc proteins was detected only after more 
than two hours. Also the abundance and activity of PiT2 is regulated by PTH 
but the mechanism may be different since no internalization of PiT2 
transporters could be detected by immunohistochemistry (236).  
Within minutes, PTH leads to an internalization of NaPi-lla that occurs at the 
intermicrovillar clefts via clathrin coated vesicles. There is no evidence for a 
recycling of internalized NaPi-lla proteins; neither there is evidence for a 
intracellular pool from which NaPi-lla proteins could be recruited. After 
endocytosis, NaPi-lla proteins colocalize with early endosomes from where 
they are sorted and  trafficked to lysosomes and degraded (98, 151, 236).  In 
contrast, NaPi-llc proteins have not been detected in a lysosomal fraction after 
PTH treatment, although the abundance in the brush border membrane was 
decreased with a delay of several hours (265). The exact mechanism involved 
in the down-regulation of the amount of NaPi-llc proteins by PTH remains to 
be determined.  
NaPi-lla was demonstrated to interact with several proteins. Among those, the 
PDZ domain containing proteins NHERF1 (sodium-proton exchanger 
regulatory factor 1) and NHERF3 (PDZK1) showed most robust interactions in 
in-vitro assays (110, 129). These interactions occur via the most C-terminal 
amino acids (TRL) of NaPi-lla. NHERF1 contains two PDZ domains, of which 
the first one interacts with NaPi-lla (110, 129) and a MERM (merlin-ezrin-
radixin-moesin) binding domain that, via ezrin, links NHERF1 to the β-actin 
cytoskeleton. As demonstrated with NHERF1 knock out mice, NHERF1 is 
instrumental for stabilizing NaPi-lla proteins at the apical membrane (63, 268). 
In these mice, the apical abundance of NaPi-lla proteins was reduced 
resulting in increased urinary phosphate excretion. Reduced abundance of 
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NaPi-lla proteins at the apical membrane was associated with accumulation in 
intracellular structures indicating an impaired targeting of NaPi-lla proteins to 
the apical membrane. Furthermore, NHERF1 plays an important role in PTH 
stimulated endocytosis of NaPi-lla. The affinity of NHERF1/NaPi-lla interaction 
is decreased by phosphorylation of a serine residue (ser77) that is located 
within the first PDZ domain of NHERF1 by either signalling cascade (PKA, 
PKC) activated by PTH (322). Consequently, increased mobility of NaPi-lla 
allocates NaPi-lla for endocytosis (323).  
In addition to NaPi-lla, NHERF1 also interacts with PTH receptor PTHR1 and 
phospholipase C (191). In agreement, apical PTH signaling, but not 
basolateral signaling was shown to be impaired in NHERF1 deficient mice 
(49). 
In addition to NHERF1, NaPi-lla strongly interacts with the four PDZ domain 
containing protein NHERF3 (PDZK1, Cap1) (129) that has been localized at 
the proximal tubular brush borders as well. However, PDZK-/- mice, exhibit a 
mild phosphaturic phenotype only under high phosphate diets (50). Besides 
NaPi-lla, NaPi-llc was shown to interact with NHERF3 (PDZK1) as well (308). 
Functional significance of this interaction was observed in PDZK1 -/- mice fed 
chronically with low phosphate diet. Compared to wild type mice, up-
regulation of NaPi-llc in PDZK1 -/-  was impaired while up-regulation of NaPi-lla 
was normal (109). These studies suggest that NHERF3 is involved in the slow 
adaptive response of NaPi-llc to low phosphate diet and does not play a role 
in the fast adaptive response of NaPi-lla.  
Moreover, the epithelial form of shank2 has been shown to interact with NaPi-
lla as well.  Microscopic analysis provided evidence that apically localized 
shank2 cotrafficks together with NaPi-lla under conditions that lead to a down-




In recent years, several new phosphaturic factors, now collectively named as 
phosphatonins, have been identified that contribute to the maintenance of 
phosphate homeostasis. Originally, the term phosphatonin has been coined to 
describe circulating phosphaturic factors that are elevated in several diseases, 
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such as oncogenic osteomalacia (OOM), autosomal dominant 
hypophosphatemic rickets (ADHR), and X-linked hypophosphatemic rickets 
(XLHR) (31, 160). These diseases are characterized by hyperphosphaturia, 
hypophosphatemia, and inappropriately normal or low levels of 1,25-
dihydroxyvitamin D3. To date, the following phosphatonins have been 
identified: fibroblast growth factor 23 (FGF23), secreted frizzled related protein 
4 (sFRP4) and matrix extracellular phosphoprotein (MEPE) (2, 31, 325).  The 
attribution of fibroblast growth factor 7 (FGF-7) is controversial since no 
phosphaturic effects in vivo could be detected. 
 
FGF23, is primarily produced and secreted by osteocytes and osteoblasts 
(92). Small levels of mRNA were detected in other tissues such as liver, 
parathyroid glands, and small intestine (2). The uncleaved, biologically active 
form of FGF23, consists of 215 amino acids. Cleavage and inactivation of 
FGF23 occurs at a subtilisin-like proprotein convertase site at position 176 
(R176XXR). Mutations at these positions have been associated with ADHR 
due to reduced cleavage and consequently increased levels of FGF23 (13, 
270). Proteolytic cleavage may also be influenced by altered O-glycosylation 
of FGF23 by UDP-N-acetyl-α-D-glactosamine: polypeptide N-acetyl-
glactosaminyltransferase (GALNT3) that has been associated with familial 
tumoral calcinosis (274).  
FGF23 has emerged as the possibly most important regulator of phosphate 
homeostasis, although, compared to PTH secretion, changes of serum 
concentrations of FGF23 occur more slowly. Synthesis and secretion of 
FGF23 is stimulated by dietary phosphate (46, 95, 231, 235,) and 1,25-
dihydroxyvitamin D3 (154). As a feedback mechanism, FGF23 inhibits the 
production of 1,25(OH)2 vitamin D3 via inhibition of 1α-hydroxylase activity and 
increase of 24-hydroxylase activity (183). FGF23 also suppresses synthesis 
and release of PTH from parathyroid glands (272). 
 
Several in-vivo and in-vitro investigations documented that the phosphaturic 
effect of FGF23 can be explained by alterations of the apical abundances of 
proximal tubular Na/Pi-cotransporters. Phosphaturia in FGF23 transgenic 
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mice correlates with reduced amounts of both NaPi-lla and NaPi-llc (166) and 
overexpression of FGF23 and in-vitro treatment of isolated proximal tubules 
affected abundances of proximal tubular apical Na/Pi-cotransporters NaPi-lla, 
NaPi-llc and PiT2 (17, 258, 291). FGF23 null mice exhibit severe 
hyperphosphatemia and have elevated serum levels of 1,25-dihydroxyvitamin 
D3 (269). 
The phosphaturic effect of FGF23 is mediated via the canonical FGF receptor 
FGFR1c and requires the membranous form of Klotho as cofactor (106, 306). 
Cellular signaling elicited by this receptor complex was described to occur via 
the MAPK kinase pathway (90, 91, 326). The exact signaling cascade 
regulating Na/Pi-cotransporters by FGF23 remains to be determined. In 
kidney, Klotho is expressed mainly in distal tubules (90). Injection of FGF23 
was shown to induce phosphorylation of MAPK in distal tubules in parallel to a 
reduction of NaPi-lla protein in proximal tubules, indicating that an unknown 
paracrine mechanism could be involved in the action of FGF23 on proximal 
tubular Na/Pi-cotransporters (90). However, low expression of klotho was 
demonstrated in proximal tubules as well (134) and therefore may suggest 
that klotho acts also in an autocrine manner in proximal tubules.  
Klotho protein is composed of two extracellular domains that show similarity to 
β-glycosidases, thus, alternatively to its FGF receptor cofactor function, Klotho 
may modify transporter function directly via hydrolysis of sugar residues. 
Evidence for such action of Klotho has been provided in in-vitro experiments. 
Incubation of isolated proximal tubular brush border membranes with 
recombinant Klotho protein leads to an inhibition of Na/Pi-cotransport (134).  
Frizzled-related protein 4 is overexpressed in OOM tumors (30, 31). sFRP-4 
elicits an increase of phosphate excretion that is caused by a decrease of 
Na/Pi-cotransporter NaPi-lla abundance (29, 30). sFRP-4 was shown to alter 
phosphorylation of beta-catenin pointing to a mechanism involving the Wnt-
signalling pathway up-stream to a down-regulation of NaPi-lla (29). 
MEPE and FGF7 were identified from tumor tissues of patients exhibiting 
renal phosphate wasting (31). MEPE, a member of the SIBLING (short 
integrin-binding ligand interacting glycoprotein) protein family, is primarily 
expressed in bone cells. The phosphaturic action of MEPE is paralled by a 
decrease of apical NaPi-lla protein abundance (85). In cell culture studies, 
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FGF7 inhibits Na/Pi-cotransport (53). Cellular mechanisms involved in the 
phosphaturic action of MEPE and possibly FGF7 are not known.  
 
Catecholamines 
Nerve endings in proximity to renal tubules release norepinephrine, which acts 
on proximal tubule to increase sodium, phosphate, and bicarbonate 
reabsorption (18). These effects are explained by a stimulatory action of 
norepinephrine on the sodium/potassium pump, as evidenced by 
norepinephrine induced increases in transport related oxygen consumption 
and ATP hydrolysis. The effect of epinephrine on renal phosphate handling 
may be indirect via stimulation of PTH secretion (96). 
In kidney, dopamine is synthesized primarily in proximal tubules (274 and its  
production is regulated by dietary intake of phosphate via stimulation of DOPA 
decarboxylase activity (321). A number of studies showed that dopamine is 
both natriuretic and phosphaturic due to autocrine/paracrine actions (105, 
111). The phosphaturic effect of dopamine has been demonstrated in several 
animal models and cultured renal cells (78, 137, 140, 167). Administration of 
dopamine or its precursors elicit reduced Na/Pi-cotransport at the brush 
border membrane (84, 137) that is explained by internalization of NaPi-lla 
cotranporters (11).  
Differential inhibition of D1 and D2 receptors indicated that stimulation of 
apically localized D1 receptors, via a cAMP/PKA pathway, increase the rate of 
internalization of NaPi-lla (11, 62). Similar as for PTH mediated internalization 
of NaPi-lla, NHERF1 plays a key role in dopamine induced internalization of 
NaPi-lla. The signaling cascade activated by dopamine leads to 
phosphorylation of Ser77 within a PDZ domain of NHERF1 resulting in a 
decreased affinity for NaPi-lla (320).  
 
Atrial Natriuretic Peptide/NO 
Atrial natriuretic factors represent a series of peptides that besides vascular 
actions also have direct effect on proximal tubular functions. Early studies 
demonstrated that ANP causes phosphaturia associated with a decrease of 
brush border membrane Na/Pi-cotransport (330).  Nitric oxide (NO) was 
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shown to regulate proximal tubular transport by autocrine/paracrine 
mechanisms (155). 
Guanylate cyclase is activated by both ANP and NO (319). In mice and 
cultured renal cells administration of ANP and NO donors resulted in a 
decrease of NaPi-lla cotransporters. These effects could be mimicked by 
pharmacological activation of protein kinase G by 8Br-cGMP and inhibited by 
protein kinase G inhibitors. In-vitro perfusion of isolated proximal tubules 
suggested the presence of ANP receptors at both membrane sites (12). At 
this time the target for activated PKG is not known.  
 
Growth Hormone 
Growth hormone (directly or indirectly mediated by insulin-like growth factor l) 
acts on renal proximal tubule to increase phosphate reabsorption (54, 122, 
124). Receptors for IGF likely reside in the basolateral membrane (124). In 
juvenile rats suppression of growth hormone reduced reabsorption of 
phosphate and abundance of the NaPi-lla cotransporter to a similar level as 
observed in adult rats (326). These observations suggest that growth 
hormone plays an important role in up-regulated phosphate reabsorption in 
young animals which likely is due to higher anabolic needs. 
 
Insulin/Glucagon 
Insulin infusions coupled with sufficient glucose to maintain euglycemia 
increase renal reabsorption of phosphate in humans (79). Renal cortical 
tubules display specific binding of insulin, and insulin added to proximal 
tubules in vitro increases Na/Pi-cotransport in brush border membrane 
vesicles derived from these tubules (123). At this time, no further information 
about the cellular mechanisms of insulin action are known. A pathway 
including the serine/threonine kinase mTOR could be envisaged as insulin 
represents a stimulator of mTOR. Accordingly, it has been shown that 
rapamycin, an inhibitor of mTOR, resulted in phosphaturia (149). Furthermore, 
insulin was proposed to have a role in the adaptive response of renal handling 
to low Pi-diet. In rats with streptozotocin-induced diabetes, no increase of 
Na/Pi-cotransport in isolated brush border membranes was detected after low 
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Pi-diet given for three days (1). Interestingly, at the whole kidney level the 
adaptive response was normal.    
Glucagon may have direct actions on the kidney to enhance calcium and 
magnesium reabsorption, probably in the thick ascending limb of Henle, but 
any effects on phosphate excretion are probably indirect (14). 
 
Glucocorticoids 
Glucocorticoids, like dexamethasone, triamcinolone, and hydrocortisone 
increase phosphate excretion by inhibition of brush border Na/Pi-cotransport 
(184). Independent from the presence of PTH, pharmacologic doses result in 
decreased phosphate reabsorption within 1-2 h (103). There is special interest 
in the relationship between glucocorticoids and phosphate transport because 
glucocorticoids participate importantly in the renal response to metabolic 
acidosis, including phosphaturia (40, 102) and chronic treatment with 
glucocorticoids leads to loss of bone mass. 
Work performed with cultured renal cells provided evidence for a genomic as 
well as for a non-genomic mechanism of glucocorticoid-induced phosphate 
excretion. The latter may be mediated by PKC rather than PKA (232, 313).  
 
Calcitonin 
Low doses of calcitonin reduce the fractional excretion of calcium and 
magnesium but have no effect on phosphate excretion; much higher dosage 
of calcitonin is required to increase phosphate excretion (52). This suggests 
that the physiological role of calcitonin is to cause renal conservation of 
calcium and magnesium, and that increased excretion of phosphate may 
represent a pharmacological effect. Nevertheless, acute administration of 
calcitonin increases phosphate excretion. Micropunture studies indicated that 
calcitonin induced inhibition of phosphate reabsorption occurs in proximal 
tubules independent of an increase of cAMP (33). Additionally, after a few 
hours, injection of calcitonin provoked decreased Na/Pi-cotransport in rat 
renal brush border membranes (329). Curiously, calcitonin has no 






Excess thyroid hormone is associated with hyperphosphatemia and increased 
renal reabsorption of phosphate that is due to altered Na/Pi-cotransport (328). 
In addition, thyroxine stimulates Na/K-ATPase activity providing increased 
driving force for Na/Pi-cotransport. Vice versa, the absence of thyroid 
hormones results in a decrease of of NaPi-lla protein abundance (4, 259) and 
increased renal loss of phosphate (217). 
 
Estrogen 
Estrogen replacement therapy during menopause results in decreased 
plasma levels of Pi that has been associated with inhibition of renal phosphate 
reabsorption (276, 295).  In a study using ovarectomized rats, inhibition of 
Na/Pi-cotransport was observed after treatment with β-estradiol compared to 
untreated rats (23). Inhibition of proximal tubular transport of phosphate by 
estrogen has been associated with a specific decrease of both NaPi-lla mRNA 
and protein (89) whereas abundance of NaPi-llc was not altered. Furthermore, 
no changes of Klotho and NHERF1 mRNA contents have been detected. 
Although estrogen receptors are expressed in proximal tubules (68), a blocker 
of the α- receptor did not prevent down-regulation of NaPi-lla; a possible 
involvement of the β-receptor has not been investigated. Also, it remains to be 
tested if down-regulation of NaPi-lla is directly mediated by estrogen or 
indirectly, e.g. by a stimulation of the production of dopamine. 
 
Stanniocalcins 
The polypeptide hormone stanniocalcin 1 (STE1) and the related STE2 are 
suggested to be involved in the homeostasis of calcium and phosphate (314). 
Human stanniocalcin 1 reduced phosphate excretion in rats due to a 
stimulation of brush border Na/Pi-cotransport (314, 316). No direct effect of 
STE2 in vivo has been examined. In cell culture, a long term inhibitory effect 
of STE2 on Na/Pi-cotransport was observed that is likely due to an inhibition 
of the NaPi-lla promoter activity (138).  
STE1 and STE2 are expressed in several tissues (138). In kidney, expression 
of STE1 has been repeatedly shown in distal tubular segments, whereas 
proximal tubular expression of STE1 remains controversial. Available data 
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therefore suggest that STE1 may act as a paracrine modulator of renal 
phosphate handling. Renal localization of STE2 is not known (138). 
Interestingly, expression of STE1 and STE2 mRNA is stimulated by 1,25-
dihydroxy-vitamin3 and STE2 mRNA is acutely decreased  by PTH (132, 281).  
 
Calcium/Magnesium 
It is not possible to provide simple answers to questions about the effects of 
calcium on phosphate excretion (271). When considering individual studies, 
one should question the following features: i) Is PTH present or absent? Or, 
can the observed effects of calcium on phosphate excretion be correlated with 
corresponding changes in PTH concentrations? ii) Are changes in calcium 
developing acutely (intravenously over minutes or hours) or chronically (over 
more than 24 hours)? iii) What are the other specific details regarding 
changes in calcium concentrations? For instance, are calcium values 
increased from low to normal, or normal to high, in vivo or in vitro? 
Direct tubular effects of calcium on phosphate transport have been studied by 
various approaches. In isolated tubules from rabbit, increasing the calcium 
concentration in both bath and the lumen caused progressive increases in 
phosphate absorption without affecting net sodium transport (250). In vivo 
microperfusion studies in parathyroidectomized rats demonstrated a decrease 
in proximal phosphate transport when calcium was omitted from the 
peritubular and intraluminal fluids, yet changes from 1.5 to 3 mM had no effect 
(304). 
In normal rats fed high magnesium diet, reabsorption of phosphate was 
increased due to increased abundances of NaPi-lla and NaPi-llc (290). This 
effect has been correlated with a decrease of PTH concentration.  
Parathyroidectomy abolished the effects of high magnesium diets on NaPi-IIa 
whereas the effect on NaPi-llc was not affected, suggesting a PTH 
independent effect of high Magnesium diet on NaPi-llc.  
 
Hypokalemia/Potassium Deficiency 
Besides impairment of systemic functions, hypokalemia/potassium deficiency 
provokes morphological changes and affects a number of renal functions 
including transport rates and metabolic processes. Hypokalemia/ potassium 
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deficiency leads to hypophosphatemia due to an increase of urinary 
phosphate excretion (141, 142, 263) that was associated with decreased 
phosphate transport in isolated proximal tubular brush border membranes (45, 
331). Of interest, abundances of Na/Pi-cotransporters are differentially 
affected by potassium deficiency. While abundances of both NaPi-llc and PiT-
2 were decreased, abundance of NaPi-lla was increased (45). In addition, lipid 
composition and membrane fluidity was altered as well. Changes of the 
contents of sphingomyelin and glucosylceramide were reported to decrease 
membrane fluidity.  
In contrast to potassium deficiency, potassium loading was shown to 
decrease urinary excretion of phosphate. Stimulation of total renal 
reabsorption of phosphate by potassium loading was shown to be dependent 
on intact parathyroid glands. Interestingly stimulation of total renal 
reabsorption of phosphate induced by intravenous injection of potassium has 
been associated with an increase of distal tubular reabsorption of phosphate 




The increase in phosphate excretion that occurs with metabolic acidosis has 
at least two physiological roles. First, it provides urinary buffer to enhance the 
excretion of acids. Second, it reduces the extracellular burden of phosphate 
that occurs from mobilization of bone mineral (176). Chronic metabolic 
acidosis in humans causes negative calcium and phosphate balance that 
results from mobilization of bone mineral (176). 
Phosphaturia occurs with metabolic acidosis induced by ammonium chloride, 
hydrochloric acid, or lactic acid, and is completely reversed by correction of 
acidemia (118). Interestingly, there is no consistent change in serum 
phosphate concentration. Thus the major factor that induces phosphaturia 
appears to be acidemia. The effects of metabolic acidosis on phosphate 
excretion occur in the absence of PTH (118). 
Sensitivity to luminal pH-values of Na/Pi-cotransporters localized at the 
proximal tubular brush border membranes may explain part of the 
phosphaturic response elicited by metabolic acidosis. In brush border 
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membrane vesicles Na/Pi cotransport activity is very sensitive to pH with 
acidic pH decreasing transport activity (10). The function of both, NaPi-lla and 
NaPi-llc is decreased by an increase of extracellular proton concentration 
(98). Part of this inhibition is related to allosteric changes in the phosphate 
transporters, which inhibit sodium activation (312). In addition to the direct and 
immediate effects of pH on phosphate transporters, acidemia over time 
eventually reduces phosphate transport by mechanisms related to 
glucocorticoids that have been shown to reduce phosphate reabsorption (102, 
318) or to elevated levels of FGF-23 (158) 
Regulation of proximal tubular Na/Pi-cotransporters by metabolic acidosis has 
been studied in rats and mice. Studies in rats revealed a decrease of NaPi-lla 
mRNA that was paralleled by a decrease of the amount of NaPi-lla proteins 
(8). In another study in rats kept on a low or normal phosphate diet, acidosis 
induced phosphaturia only in animals on normal phosphate intake and no 
decrease in NaPi-IIa, NaPi-IIc or PiT2 expression was found in rats on low 
phosphate diet (310). Similarly, in mice, metabolic acidosis provoked a 
decrease of NaPi-llc and NaPi-lla mRNA expression, however, protein content 
of both Na/Pi-cotransporters was increased (230). Thus, at least in mice, 
metabolic acidosis induced phosphaturia cannot be explained by a down-
regulation of type ll Na/Pi-cotransporters. 
 
1,25-Dihydroxyvitamin D3   
The active form of vitamin D, 1, 25-dihydroxyvitamin D3 (1, 25-(OH)2D3), is 
primarily formed in kidney proximal tubules by 1α-hydroxlases that are located 
in the inner mitochondrial membrane. The net serum concentration of 1,25-
dihydroxyvitamin D3 is determined by complex regulations of the 1α-
hydroxylase as well as 24-hydroxylase by PTH, FGF23 and dietary phosphate 
(88, 183). Under normal conditions 1,25-dihydroxyvitamin D3 appears to have 
no demonstratable effects on renal handling of phosphate, but rather on 
intestinal absorption of phosphate (207). A phosphaturic action of 1, 25-
(OH)2D3 appears to be more indirect as increased levels of 1,25-(OH)2D3 
stimulate release of FGF23 from bone that in turn inhibits reabsorption of 
phosphate. By using 1,25-(OH)2D3 deficient rats, administration of 1,25-
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(OH)2D3 was shown to increase NaPi-lla abundance, likely occurring via a 
transcriptional mechanism (282).  
Reduced dietary intake of phosphate increases 1α-hydroxylase activity in 
proximal tubules and serum concentration of 1,25-(OH)2D3 (332). In animal 
models, increase of both activity and mRNA content of 1α-hydroxyalse was 
delayed by approximately 24 h after the onset of reduced dietary intake of 
phosphate. In hypophysectomized animals this increase was blunted and 
therefore appears to be dependent on growth hormones (285). The late onset 
of 1,25-(OH)2D3 production induced by low Pi-diet makes it unlikely that 1,25-
(OH)2D3 is involved in the rapid adaptive response to low Pi-diet. In 
agreement, an intact acute adaptive response of renal Na/Pi-cotransport has 
been demonstrated in 1α-hydroxylase knock out mice (51).  
 
Dietary Intake of Phosphate 
Renal reabsorptive capacity for phosphate varies and adapts profoundly in 
response to dietary intake of phosphate (289, 303). Phosphate restriction 
enhances and high phosphate diets reduce the intrinsic capacity of the kidney 
to reabsorb phosphate. It is useful to distinguish between phosphate 
restriction (short term) and phosphate depletion (over a long period of time). 
Renal adaptation to altered intake of dietary phosphate occurs rapidly -within 
hours- and specifically alters the rate of proximal tubular Na/Pi-cotransport 
(177, 181, 249). Phosphate depletion represents a more severe state that 
requires 2-4 weeks of phosphate deprivation and is associated with impaired 
energy metabolism and multiple reabsorptive defects along the nephron, 
including those for glucose, amino acids, bicarbonate, and calcium (156). In 
contrast to reduced intake of phosphate by dietary content of phosphate, 
fasting provoked only minor changes of renal excretion of phosphate and 
Na/Pi-cotransport actitvity in brush border membrane vesicles (150).  
The proximal tubule is the major nephron site at which adaptation to 
phosphate restriction occurs. Both early and late portions of the proximal 
tubule from both superficial and juxtamedullary nephrons are involved in 
adaptative changes (125). The effect of dietary adaptation on Na/Pi-
cotransport has been demonstrated both in isolated proximal tubules (303) 
and isolated brush border membrane vesicles and is manifested by an 
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increase in Vmax without changes in Km-value (58, 59, 277). Rapid (two hours) 
adaptation to phosphate restriction leads to increased Na/Pi-cotransport in rat 
brush border vesicles due to an increase of NaPi-lla abundance (186, 249). 
Similarly, rapid down-regulation of Na/Pi-cotransport and abundance of NaPi-
lla protein is observed after intake of excessive phosphate (186, 249). As 
observed after PTH injection, acute down-regulation of NaPi-lla protein 
induced by high Pi-diet involves endocytosis and lysosomal degradation of 
NaPi-lla proteins (151).  
Short-term changes of dietary phosphate intake primarily affect abundance of 
NaPi-lla protein, whereas changes in the abundance of NaPi-llc and PiT-2 
Na/Pi-cotransporters are slower (309) and likely occur by different 
mechanisms. For instance, although apical content of NaPi-llc is reduced by 
high dietary phosphate, total cellular content was not altered, suggesting that 
the mechanism of regulation of NaPi-llc is distinct from the NaPi-lla 
cotransporter (265).Neither the nature nor the locus of possible phosphate 
signaling pathways that provoke proximal tubular adaptation of Na/Pi-
cotransporters in response to changes in phosphate intake are known yet. 
Among the various candidates, PTH, calcitonin, vitamin D metabolites, 
thyroxine, growth hormone, FGF23, and, the pituitary gland have been 
discarded (34, 83). When directly introduced into the rat duodenum, 
phosphate elicited an increase of phosphate excretion within 15 min that was 
independent of altered serum levels of PTH, FGF23, serum phosphate 
concentration and was also not dependent on renal nerves (32, 161). Based 
on this data, a –yet unknown- intestinal endocrine factor (termed 'intestinal 
phosphatonin') was proposed that could participates in an intestine-renal 
signalling axis. However, it has also been shown, that contact with intestinal 
mucosa can be bypassed by intravenous injection of a phosphate bolus. 
Continuous infusion of phosphate into thyroparathyroidectomized rats adapted 
to low phosphate diet has been shown to down-regulate brush border 
membrane Na/Pi-cotransport within a short period of time (58). This suggests 
that serum concentration of phosphate may represent the signal for renal 
adaptation of Na/Pi-cotransport, and secondly that the signaling mechanisms 






Inorganic sulfate is taken up by diet and is critical for several basic processes 
such as forming very stable disulfide bonds within or between proteins (e.g. in 
keratins), forming part of enzymes or vitamins such as coenzyme A, thiamine 
and biotin, or being part of redox systems such as glutathione and 
thioredoxins. Sulfate plays an important role in detoxification by the liver, and 
for the structural integrity of bone and cartilage.  
The main source of sulfate is dietary intake of protein comprised of sulfur-
containing amino acids, mostly cysteine and methionine. Additional sources 
are water which may contain significant amounts of sulfate. Free inorganic 
sulfate is readily absorbed from diet in a Na+-dependent process occurring 
mostly in the small intestine and is mediated by mechanisms and molecules 
similar if not identical to renal reabsorption of inorganic sulfate (see below) 
(97, 223). Daily intake of sulfate has been reported to be in the range of 0.2 to 
1.5 g (2.1–15.8 mmol)/day (97). 
Protein catabolism, mostly in liver, releases sulfate from cysteine and 
methionine containing proteins in parallel with elevated ureagenesis thereby 
correlating urinary sulfate and urea excretion (114, 133, 252).  Urinary sulfate 
excretion may be even used as a marker of catabolism of sulfur-containing 
proteins (121, 131). 
 
 
PLASMA SULFATE CONCENTRATION 
In plasma, inorganic sulfate concentrations range between 0.2 and 1.1 mmol/l 
with an average of about 0.6 mmol/l (22). The main source of inorganic sulfate 
in the body is dietary uptake and metabolism of the sulfur containing amino 
acids cysteine, methionine, and to a lesser extent homocysteine and taurine.  
In humans, low circulating sulfate levels are not associated with specific 
diseases, however, rare inborn disorders of organ and cell specific sulfate 
transporters have been reported to cause severe malformations such as 





RENAL HANDLING OF SULFATE  
Because SO4
2- is freely filtered (113) the rate of urinary excretion is 
determined by the rate of reabsorption and secretion along the proximal 
tubule. Sulfate reabsorption is an active process, regulated, and saturable 
(182). With increasing intake, the filtered sulfate load exceeds the threshold 
for maximal tubular reabsorption and increasing amounts of sulfate appear in 
urine. Under normal dietary sulfate supply, the fractional excretion of sulfate is 
approximately 10 % in dog (113), whereas in rat the fractional excretion is 
around 30 % with plasma concentrations of sulfate of approximately 0.7 – 1 
mmol/L (22, 159, 222). 
The mechanisms by which sulfate is transported along the nephron have been 
thoroughly examined using micropuncture in vivo (67, 130, 296, 297, 298, 
299, 300, 301, 302, 305),  microperfusion of isolated tubules ex vivo (44 ), and 
isolation of vesicles of brush border and basolateral membranes (16, 116, 
188, 189, 242, 260, 294). Several aspects have been reviewed recently (193, 
200, 202, 203, 204). 
Sulfate is actively transported in the proximal tubule across the luminal brush 
border membrane as well as via the basolateral membrane of cells (44, 
67,189, 241, 260, 294, 296, 297, 298, 299, 300, 301, 302, 305). Collectively, 
many studies demonstrated using micropuncture, isolated brush border and 
basolateral membrane vesicles that sulfate transport occurs mostly by a Na+-
dependent transport process across the brush border membrane and by 
sulfate/anion exchange in the basolateral membrane (Figure 2).  
Brush border membrane vesicle studies showed a Na+-dependent transport 
process with an estimated affinity for sulfate of approximately 600 µM and for 
sodium with about 36 mM (260, 294). Because the Hill coefficient was close to 
2 it was assumed that the transport process was electroneutral. Following the 
cloning of NaSi1 transport induced currents were demonstrated that are due 
to the cotransport of 3 Na+ ions per sulfate (48). The luminal, Na+-dependent 
transport process interacts with thiosulfate, selenate, chromate, and 
molybdate but not phosphate (67, 297).  
The luminal membrane, however, has also an additional transport system 
mediating the exchange of intracellular sulfate for extracellular anions, most 
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likely bicarbonate and oxalate. Thereby the proximal tubule is able to secrete 
sulfate into urine (44, 81, 163, 242, 284). Whether the latter transport pathway 
characterized mostly in isolated brush border membrane vesicles has 
physiological relevance depends on the availability of intracellular and 
extracellular transport substrates. In mice lacking CFEX (possibly the 
molecular correlate of this transport activity) no sulfate related phenotype has 
been reported to date (see below). 
In contrast, the basolateral transport process is mediated by an anion 
exchange mechanism releasing sulfate into the extracellular space in 
exchange for anions such as bicarbonate, oxalate or hydroxyl ions (44, 120, 
162, 188). The transport mechanism is inhibited by the stilbene derivates 
DIDS and SITS, nonspecific inhibitors of various anion transport systems (16). 
Of note, the transport substrates and sensitivity of the luminal and basolateral 
sulfate exchangers are different suggesting that each transport systems are 
encoded by distinct genes. 
 
 
MOLECULAR IDENTIFICATION OF RENAL SULFATE TRANSPORTERS  
NaSi1 (SLC13A1) 
NaSi1 (NaS1, SLC13A1) was first identified by expression cloning from a rat 
kidney cDNA library in Xenopus oocytes and shown to mediate Na+-
dependent uptake of sulfate (20, 196). Homologues from other species 
including mouse and man have been further identified (20, 168). The human 
gene consists of 15 exons and is localized on chromosome 7q31-7q32 (168). 
The NaSi1 protein consists of 595 amino acids and is predicted to form a 
protein with 13 transmembrane domains (20, 168). 
Transport of sulfate by NaSi1 is electrogenic and kinetic analysis suggests 
that probably 3 Na+ ions are cotransported with one SO4
2- ion per transport 
cycle by NaSi1 (48). NaSi1 transports SO4
2-, thiosulfates, and selenate with 
affinities in the range of 100-500 µM, respectively, and sodium with an 
apparent Km of about 20 mM (48, 196). Structural and phylogenetic features 
of NaSi1 have been reviewed in more detail elsewhere (200). 
NaSi1 is expressed predominantly in kidney and small intestine. There it 
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localizes to the apical brush border membrane of early proximal tubule cells 
and enterocytes of the small intestine and possibly also colon (20, 228). Weak 
expression may occur also in testis, adrenal glands and adipose tissue. In rat 
and mouse kidney, NaSi1 immunostaining is predominant in the proximal 
convoluted tubule (S1 and S2 segments) and weaker in the straight proximal 
tubule (S3 segment). NaSi1 staining is found in cortical and juxtamedullary 
nephrons (65, 187).  
Deletion of NaSi1 in mice demonstrated that apical Na+-dependent sulfate 
transport is completely accounted for by NaSi-1 and mice display a sulfate 
losing phenotype (hypersulfaturia) (69). Hyposulfatemia is the consequence of 
both urinary sulfate losses as well as impaired intestinal uptake. NaSi1 
deficient mice have been a useful tool to study the physiological roles of 
sulfate and the consequences of hyposulfatemia as exemplified by reduced 
fertility, growth retardation, impaired hepatic detoxification of drugs, changes 
in hepatic lipid metabolism, and impairment of CNS functions (69, 70, 71, 72, 
73, 76, 77, 173, 174). Thus, intestinal uptake and renal reabsorption of sulfate 




SAT1 (SLC26A1) belongs to the family of SLC26 anion exchangers 
(87,193,221). Several members of this family have been shown to transport 
sulfate, most notably SAT1 (38, 194, DSTS (SLC26A2) (127, 147) and CFEX 
/PAT1 (Chloride-formate exchanger/ putative anion transporter 1 (SLC26A6) 
(144), and SLC26A11 (311).  
SAT1 was identified by expression cloning (38). The protein consists of 703 
amino acids and has 12 putative transmembrane domains. When  expressed 
in heterologous expression systems SAT1 mediates the transport of a variety 
of anions including sulfate, bicarbonate, and oxalate. Chloride may also be 
transported but with low affinity and efficiency (157). This transport activity is 
mediated by an obligatory exchange mechanism where intracellular substrate 
is exchanged for extracellular substrate. The transporter interacts also with 
probenecid, selenate, phenol red, tungstate and DIDS. Whether these 
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substances are only inhibitors or transport substrates has not been fully 
explored (38). 
SAT1 mRNA has been detected in many organs including kidney, liver, small 
intestine, skeletal muscle and brain (38). In rodent kidney, SAT1 is localized to 
the basolateral membrane of the proximal tubule with more intense staining of 
proximal convoluted tubules (e.g. S1 and S2 segments) than straight proximal 
tubules (e.g. S3 segment) (146) paralleling the apical localization of NaSi1 in 
the same segments (187). The localization of SAT1 in human kidney has not 
been reported to date. 
In vivo studies with sat1 deficient mice provided evidence for a primary defect 
in renal sulfate handling but not oxalate or bicarbonate (see below) suggesting 
that SAT1 serves mostly the transepithelial transport of sulfate (75). SAT1 KO 
mice show renal sulfate wasting and hyposulfatemia consistent with a major 
role of SAT1 in the release of sulfate from proximal tubule cells into the 
basolateral space. The physiological counter-ion is likely bicarbonate. Even 
though oxalate interacts with the transporter with a higher affinity, the very low 
concentrations measured in normal human subjects and animals (in the range 
of 1-5 µM) and the high concentrations of bicarbonate (approx. 25 mM) at the 
basolateral membrane favour exchange of intracellular sulfate for extracellular 
bicarbonate (or chloride) (157). Interestingly, sat1 deficient mice also 
developed oxalate kidney stones, reminiscent of slc26a6 deficient mice (see 




CFEX (SLC26A6, also known as PAT1) is expressed in the proximal tubule of 
the kidney and the small intestine and localizes to the apical brush border 
membrane (152). CFEX mediates the exchange of various anions including 
chloride, bicarbonate, oxalate, and also sulfate (144). Considering 
physiological concentrations and distribution (luminal vs intracellular) of these 
anions, sulfate is not a major substrate in vivo and might be rather excreted 
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than reabsorbed by CFEX. Mice lacking CFEX (Slc26a6-/-) have no apparent 
abnormality of sulfate homeostasis but develop massive hyperoxaluria and 
oxalate kidney stones (143). 
 
REGULATION OF SULFATE EXCRETION 
Dietary Adaptation to high and low Sulfate Intake 
Adaptive mechanisms in the proximal tubule are of primary importance in the 
regulation of systemic sulfate homeostasis. These adaptive changes in renal 
sulfate reabsorption in response to dietary sulfate intake are similar to those 
demonstrated for phosphate and allow for constant plasma sulfate 
concentrations. Dietary sulfate deprivation results in a significant decline of 
the renal sulfate clearance and the urinary excretion rate of sulfate (26, 199, 
226, 255).  Clearance experiments in guinea pigs fed for 6-10 days with low-
sulfate diet (0.13%) demonstrated 86-91% fractional sulfate reabsorption at 
normal plasma sulfate concentrations while animals on high-sulfate diet 
(0.13% supplemented with 300 mg/kg/day sodium sulfate) decreased renal 
sulfate excretion to 55-70% (226). Similarly, dietary sulfate deprivation in rats 
exhibited decreased urinary excretion rates and renal clearance values after 8 
days of treatment while serum sulfate concentrations were unchanged. In vitro 
transport studies in brush border membrane (BBM) and basolateral 
membrane (BLM) vesicles isolated from rats stabilized on either low 
methionine or control diets for 7-9 days showed an increase of the Vmax for 
BBM sodium dependent sulfate transport in animals on low methionine diet 
(26). In contrast, in BBM vesicles of Nas1-deficient mice sodium sulfate 
transport was reduced by 90% (69). Thus, the increase in renal BBM 
sodium/sulfate cotransport is a key mechanism in the adaptive response to 
tubular sulfate handling while tubular secretion, if any, is negligible in rats and 
humans. More recent studies confirmed these findings and shed light on the 
cellular mechanisms involved. Rats treated with low methionine diet (0% and 
0.3%) were able to maintain normal serum sulfate levels and exhibited 
marked increases in NaSi-1 cotransporter mRNA and protein levels (255). 
Accordingly, urinary sulfate excretion rate and renal sulfate clearance were 
significantly decreased approaching zero. However, animals on 0% 
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methionine diet and normal serum sulfate levels were growth retarded with 
loss of muscle mass suggestive of maintained serum sulfate levels due to 
muscle catabolism. Animals fed with 0.3% methionine diet were able to 
maintain body and muscle weight indicating sufficient adaptive renal sulfate 
reabsorptive mechanisms. Animals on high methionine diet (2.46%) showed 
unchanged serum sulfate levels associated with lower NaSi-1 mRNA  
abundance (255). Another study from Markovich et al. highlighted the crucial 
role of NaSi-1 in regulation of plasma sulfate concentration by using different 
sulfate diets (199). High sulfate diet in rats resulted in a marked decrease of 
BBMV sodium/sulfate cotransport activity paralleled by a significant decrease 
in NaSi-1 mRNA and BBM protein abundance. Both studies from Markovich 
and Sagawa et al. concluded that NaSi-1 plays a major role in maintaining 
serum sulfate concentrations within the physiological range, even NaSi-1 
alone may not be responsible for the raised sulfate excretion in animals on 
high sulfate diet suggestive of either similar absorptive mechanisms or 
additional secretory processes being involved. The regulation of Sat-1 




Serum sulfate levels are decreased in hypothyroid patients and higher in 
hyperthyroid patients (283). Thyroid hormone (T3, triiodothyronine) increases 
the maximum transport capacity for sodium/ sulfate cotransport in mouse 
renal BBM vesicles while serum sulfate concentrations were unchanged 
(286). The absence of an effect of T3 on serum sulfate levels may be due to 
increased cellular uptake and utilization of sulfate, inhibition of renal sulfate 
reabsorption in the distal nephron, reduced intestinal sulfate absorption, or a 
combination of all. Similarly, experimental hypothroidism in rats decreases 
serum sulfate concentrations, lowers renal fractional reabsorption of sulfate 
and creatinine clearance. Sodium-dependent sulfate uptake into BBMV is 
reduced while Km values are not different (257). In contrast, there were no 
significant differences in Km and Vmax for the sulfate/ anion exchange process 
in basolateral membrane vesicles. NaSi-1 mRNA and protein levels were 
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significantly reduced in hypothyroid rats indicating that hypothyroidism affects 
NaSi-1 mRNA and/or protein expression. The Nas1 promoter region contains 
T3 responsive elements (74).   
                         
Vitamin D3 
Renal sulfate reabsorption has been shown to be regulated by Vitamin D3 
status. Vitamin D-deficient rats develop hyposulfatemia, enhance fractional 
excretion of sulfate, and decrease renal sodium sulfate cotransport activity 
(93). The changes in sodium sulfate cotransport activity are caused by a 
decrease of Vmax but not Km of the transport system paralleled by reduction of 
both NaSi-1 cotransporter protein and mRNA levels. Vitamin D3 
supplementation corrects hyposulfatemia, normalizes fractional sulfate 
excretion, and normalizes NaSi-1 mRNA and protein levels. Most likely the 
active 1,25(OH)2D3, but not plasma calcium nor PTH levels are responsible 
for the alterations of NaSi-1 expression and activity in this model. 1,25-
(OH)2D3 stimulates the transcriptional activation of the Nas1 promoter. 
However, Sat-1 mRNA and protein levels in the kidney and liver are not 
altered by vitamin D3 deficiency (21). Mice lacking the vitamin D receptor 
show a significant increase of urinary sulfate excretion by 40% paralleled by a 
fall in serum sulfate concentrations of 50% (39). NaSi-1 mRNA levels in the 
kidney are markedly decreased by 70% whereas intestinal NaSi-1 levels are 
not altered. The impact of vitamin D3 on NaSi-1 expression and sulfate 
metabolism is independent of its effect on calcium metabolism, since similar 
results were observed in these animals after normalization of blood calcium 
levels. In addition, treatment of wild-type mice with vitamin D3 increases renal 
NaSi-1 mRNA abundance. Taken together, the data provide evidence that 




Glucocorticoids reduce renal sulfate reabsorption in rat, chicken and winter 
flounder (247,248,254). Systemic treatment with the glucocorticoid, 
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dexamethasone, decreased sodium dependent sulfate transport in chick renal 
BBM due to decreases in the maximum transport capacity Vmax of ~ 50% 
without changes in Km or any other sulfate transport processes in either BBM 
or BLM (247). Similar results have been obtained from the marine winter 
flounder when treated with dexamethasone. Transepithelial sulfate transport 
in flounder renal tubule primary monolayer cultures treated with 
hydrocortisone was significantly higher than in cortisol-free tissue (247). 
Further evidence for the role of glucocorticoids in regulation of renal sulfate 
transport was provided from experiments in adrenalectomized rats that were 
either treated with methylprednisolone (MPL) or vehicle. NaSi-1 mRNA and 
protein levels were reduced in kidney cortex of MPL-treated animals that was 
paralleled by a 2-fold increase in urinary sulfate excretion and almost 3-fold 
increase in renal sulfate clearance (254). Changes in NaSi-1 mRNA and 
protein expression were time-dependent. mRNA levels were significantly 
decreased after 4 and 6h after a single dose MPL. Protein expression was 
significantly diminished after 4, 6, and 12h after MPL administration. 
Accordingly, the Vmax for sodium sulfate cotransport in the BBM was 
significantly decreased whereas the apparent Km values or sulfate anion 
exchange in the BLM were unchanged in MPL-treated adrenalectomized rats 
(254). Finally, Beck and Markovich described the presence of five putative 
glucocorticoid responsive elements in the Nas1 promoter region (20) 
suggesting that glucocorticoids in fact directly regulate Nas1 gene 
transcription (202).   
 
Growth Hormone/Ageing 
Sulfate reabsorption by the kidney in young animals or humans is higher than 
in adult or aged individuals.  In immature guinea pigs urinary sulfate excretion 
is low and and increases with aging (227). In young animals, low-sulfate diet 
did not appreciably stimulate Vmax whereas a high-sulfate diet resulted in a 
decrease of Vmax with no changes of Km in any age group indicating that renal 
sulfate uptake responds to conditions with increased need of sulfate such as 
growth. In contrast, aged rats showed a higher sulfate excretion rate when 
compared to young animals without changes in serum sulfate concentrations 
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(15). Cell culture studies using Madin-Darby canine kidney (MDCK) cells 
stably transfected with NaSi-1 increased sodium sulfate cotransport after 
incubation with growth hormone (GH) and insulin-like growth factor I (IGF-I) 
(172). A recent study examined changes in NaSi-1 mRNA and protein levels 
in old rats (22-23 months old) and compared them with adult rats (9-10 
months). Both NaSi-1 mRNA and protein abundance were significantly lower 
in the aged animals and transiently increased after treatment with growth 
hormone (256). The data suggest that aging in animals is associated with a 




Changes of blood pH such as metabolic acidosis cause adaptive changes in 
the activity of several proximal tubule transport proteins such as the apical 
sodium proton exchanger, the vacuolar H+-ATPase, and the basolateral 
sodium bicarbonate cotransporter (3, 56, 239). Children with classic renal 
tubular acidosis have significantly elevated renal sulfate excretion when 
compared to weight-matched controls (57). Similarly, in rats induction of 
metabolic acidosis increases significantly the fractional sulfate excretion (104). 
Puttaparthi et al. investigated the influence of metabolic acidosis on NaSi-1 
cotransport activity, protein and mRNA expression (243). Acute acidosis (6-
24h) and chronic (10 days) acidosis were induced in rats with NH4Cl in 
drinking water and chow. Increased urinary sulfate excretion correlated with 
decreased sodium dependent sulfate cotransport activity in BBM vesicles of 
acidotic rats (2.4-fold). Accordingly, both cortical NaSi-1 mRNA abundance 
and BBM NaSi-1 protein expression were decreased by 2.8- and 2.2-fold, 
respectively. The reduction in sodium dependent sulfate cotransport activity 
was detectable after 24h, but not after 12h, of metabolic acidosis. The data 
suggest that decreased mRNA and protein abundance of NaSi-1 and reduced 
BBM NaSi-1 cotransport activity may play a crucial role in the inhibition of 
NaSi-1 activity by metabolic acidosis. In the marine teleost flounder acidosis 
similarly increases renal sulfate excretion (233). Primary cultures of the winter 
flounder renal proximal tubule epithelium were mounted in Ussing chambers 
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and metabolic acidosis mimicked by reducing the interstitial pH to 7.1 
(normally 7.7). Sulfate net secretion in flounder proximal tubule cells was 
stimulated by 41% in metabolic acidosis when compared to paired isohydric 
controls and prevented by administration of the carbonic anhydrase inhibitor 
methazolamide. Also, administration of EIPA (a pyrazine-ring substituted 
amiloride derivative blocking NHE3 activity) to the lumen blocked this 
stimulation. Thus, carbonic anhydrase and BBM sodium proton exchanger 
activity may be required in this model for the acute stimulation of sulfate 
secretion by acidosis. In summary, metabolic acidosis reduces the expression 
of the major BBM sodium sulfate cotransporter NaSi-1 and thereby affects 
sulfate homeostasis.  
 
Hypokalemia 
Hypokalemia has been shown to modulate several proximal tubule transport 
proteins (178, 273). Rats that were treated for 7 days with a potassium-
deficient diet had hyposulfatemia, increased fractional sulfate excretion, and a 
significant decrease of the BBM sodium/sulfate cotransport activity (201). The 
reduction in BBM sodium/sulfate cotransport activity was correlated with 
decreases in cortical NaSi-1 mRNA and BBM protein expression. Accordingly, 
Xenopus oocytes injected with mRNA from K+-deficient rats showed a 
significant reduction in sodium sulfate cotransport but no changes in L-leucine 
uptake suggesting that in low-K+ diet down-regulation of NaSi-1 mRNA and 
protein is the potential underlying mechanism involved.  
 
Pregnancy and postnatal Growth 
As described above, during postnatal growth renal sulfate reabsorption is 
increased (170, 227, 234). In children an age-dependent curvilinear 
regression exists for serum sulfate concentrations showing highest serum 
sulfate levels at birth (0.47 mmol/l) which decrease constantly to 0.33 mmol/l 
during the following three years of life (60). In guinea pigs, the decrease in 
renal sulfate excretion with age was based on significantly decreased Vmax 
values for sodium dependent sulfate cotransport in BBM while Km values were 
not different (170). Using pregnant and non-pregnant animals Vmax and Km 
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values for BBM sulfate transport were significantly higher in pregnant animals. 
In contrast, sulfate anion exchange in BLM was unchanged among the 
different age groups. However, in pregnant guinea pigs Km of the BLM sulfate 
transport was significantly higher while Vmax was not different when compared 
to non-pregnant animals. A study looking at the ontogeny of renal sulfate 
transporter expression during postnatal maturation in 1 to 77 days old rats 
revealed that mRNA expression of both NaSi-1 and Sat-1 increase during the 
first 2 postnatal weeks (195). However, Sat-1 protein abundance increased in 
parallel while NaSi-1 protein levels remained steady. In conclusion, several 
studies indicate that sulfate is conserved in young and pregnant animals due 
to stimulated proximal tubule sulfate uptake as well as increased expression 
of both transporters involved in renal sulfate reabsorption, namely NaSi-1 and 
Sat-1, respectively. These changes may reflect conditions of increased need 
for sulfate substrates during growth and pregnancy.  
 
Membrane Fluidity 
The activity and kinetics of membrane transport proteins have been described 
to be affected by membrane fluidity. Sodium-dependent renal glucose and 
phosphate transport have been shown to be altered by changes in membrane 
fluidity (179, 280). In MDCK cells stably transfected with NaSi-1 preincubation 
with cholesterol significantly decreased the Vmax for sodium dependent sulfate 
transport with no changes in Km while addition of benzyl alcohol stimulated 
sulfate uptake by 20% (171). These changes correlated with decreased 
membrane fluidity, measured by the fluorescence polarization of 1,6-diphenyl 
1,3,5-hexatriene (DPH), after incubation with cholesterol and increased 
membrane fluidity following administration of benzyl alcohol.  
 
Non-steroidal anti-inflammatory Drugs (NSAIDs) 
Non-steroidal anti inflammatory drugs (NSAIDs) such as Indomethacin, 
Salicylic acid, Tiaprofenic acid, and Ibuprofen modulate renal sulfate 
clearance (24, 25, 66, 218, 219, 220, 253). Rats infused with Ibuprofen or 
Indomethacin demonstrated a markedly increased renal sulfate clearance 
(218). Many of these drugs affect prostaglandin synthesis. PGE2 alone does 
not alter renal sulfate clearance whereas PGE2 adminstration is able to 
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prevent the effects of Ibuprofen or Indomethacin on renal sulfate clearance. 
Moreover, Indomethacin, Ibuprofen, and Tiaprofenic acid may directly affect 
renal sulfate transport in rat kidney BBM and BLM vesicles (24). The effects of 
Ibuprofen on basolateral sulfate transport are controversial. Treatment of rats 
resulted in a decrease of the sodium-dependent sulfate cotransport capacity 
in BBM vesicles with unchanged Km. In contrast, BLM sulfate transport was 
not affected. The decreased BBM sulfate transport was paralleled by a 
significant down-regulation of NaSi-1 mRNA and protein expression (253). 
Among all three NSAIDs, Indomethacin has the strongest inhibitory effect on 
renal sulfate handling. Also effects of Salicylic acid on renal sulfate transport 
are controversial. Direct incubation of BBM and BLM vesicles demonstrated 
significantly lower transport of sulfate whereby the Ki of Salicylic acid was 
much lower for BLM transport (66). However, part of these data is in contrast 
to previous studies where Salicylic acid did not inhibit sulfate transport across 
the BLM in micropuncture studies (301). Thus, NSAID affect renal sulfate 
transport, but the mechanim(s) underlying this effect have not been clarified. 
 
Chronic renal Failure 
Hypersulfatemia as well as hyperphosphatemia are present in patients with 
chronic renal failure (101, 212, 213, 214, 283). In patients on maintenance 
hemodialysis an eight-fold increase of plasma sulfate concentrations is 
observed (192). Similar observations were made in children with chronic 
kidney disease (212). Here, plasma sulfate concentrations were inversely 
correlated with glomerular filtration rate and highest in children treated with 
regular dialysis.  In rats with experimental chronic renal failure (subtotal 
nephrectomy), hypersulfatemia was detectable as early as three weeks after 
subtotal nephrectomy, rose further after six weeks and was paralleled by 
twofold increase of fractional renal sulfate excretion (94). In these kidneys, 
NaSi-1 and Sat-1 total protein expression was decreased due to loss of 
functional kidney tissue while relative NaSi-1 cotransporter abundance was 
increased. Also hypersulfatemia despite of increased renal sulfate excretion 
could not be clearly explained. Human studies suggest a role for 
hypersulfatemia in the development of hyperparathyroidism (214). Patients 
with chronic renal failure demonstrated a positive correlation between plasma 
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sulfate and serum creatinine concentrations. In contrast, ionized calcium was 
inversely correlated with phosphate but also sulfate and parathyroid hormone. 
Calcium is able to bind sulfate and build calcium sulfate complexes. The 
resultant fall of ionized calcium might stimulate parathyroid hormone secretion 
by the parathyroid glands. Accordingly, in children on hemodialysis 
hyperparathyroidism occurs with even normal calcium levels (211). Taken 
together, hypersulfatemia in chronic renal failure might play a role in the 
development of secondary hyperparathyroidism and renal osteodystrophy by 
aggravating complex formation with calcium.  
 
Heavy Metals 
Heavy metal intoxication can result in a generalized dysfunction of the 
proximal tubule including proteinuria, glucosuria, phosphaturia, and sulfaturia 
(128, 215, 237, 307). The effect of several heavy metals on both renal sulfate 
transport proteins, NaSi-1 and Sat-1, respectively was examined (197, 198). 
Mercury strongly inhibited sodium dependent sulfate cotransport in Xenopus 
oocytes by decreasing both Vmax and Km of sulfate transport by NaSi-1 (197). 
Lead also markedly inhibited NaSi-1 mediated sulfate uptake, however, only 
Vmax was decreased while Km was unchanged. In contrast to Mercury, this 
inhibition was fully reversible. Compared to Mercury and Lead, Cadmium 
contributed to a small decrease in Vmax and thus to a weak inhibition of NaSi-1 
transport, which was fully reversible similar to lead. Of note, a previous study 
performed in rats demonstrated no changes in sulfate uptake in Cadmium-
treated animals (128). Similar to mercury, chromium also inhibited NaSi-1 by 
decreasing both Vmax and Km of sulfate transport by approximately 7-fold 
which was again fully reversible. Similar to NaSi-1, the activity of the sulfate 
transporter Sat-1 was also inhibited by the heavy metals mercury, lead, 
cadmium, and chromium (197). Mercury inhibited Sat-1 mediated sulfate 
transport in Xenopus oocytes by reduction of Vmax by 8-fold with no changes 
of Km and was similar to NaSi-1 not reversible by simple washout. In contrast 
to NaSi-1, lead did not affect Sat-1 mediated sulfate uptake. Relatively high 
millimolar concentrations of cadmium were needed to induce significant 
inhibition of sulfate uptake by reducing Vmax but not Km. Chromium only 







Figure 1: Model of a proximal tubule cell depicting transport pathways of 
phosphate across the luminal and basolateral membrane. On the luminal 
brush border membrane at least three transporters exist that can mediate 
sodium-dependent phosphate transport. The Na+-dependent uptake of 
phosphate from primary urine is mediated by NaPi-lla, NaPi-llc and PiT-2. The 
relative contribution of these three phosphate transporters may differ among 
different species. These transporters are energized by the membrane 
potential and Na+ gradient generated by basolateral Na+/K+-ATPases. 
Phosphate exits proximal tubular cells across the basolateral membrane by a 
yet unknown transport pathway.  
 
Figure 2 
Model of a proximal tubule cell (early proximal tubule) depicting transport 
pathways of sulfate across the luminal and basolateral membrane. On the 
luminal brush border membrane at least two transporters exist that can 
mediate sulfate transport. The Na+-dependent uptake of sulfate from primary 
urine is mediated by the NaSi sulfate transporter. This transporter is energized 
by the membrane potential and Na+ gradient generated by basolateral Na+,K+-
ATPases. Sulfate may also be excreted into primary urine by an anion 
exchanger, most likely CFEX, that transports sulfate in exchange for oxalate, 
chloride or bicarbonate. This transport pathway is also linked to Na+-H+-
exchange mediated mostly by NHE3. Sulfate exits proximal tubular cells 
across the basolateral membrane in exchange for extracellular anions through 
the SAT1 anion exchanger. Intracellular bicarbonate is excreted into the 
basolateral space by the NBCe1 electrogenic Na+-HCO3
- -cotransporter. Also 
this transport process is linked to the NHE3 transporter and carbonic 
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